Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 3, 2012, Pages 591-599

  Asmus, Lutz R ^a   Kaufmann, Béatrice ^a   Melander, Louise ^b   Weiss, Torsten ^b   Schwach, Grégoire ^b   Gurny, Robert ^a   Möller, Michael ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Implants; Parenteral formulations; Peptides; Polyesters; Sustained release; Triptorelin

Indexed keywords

EXCIPIENT; HEXYLSUBSITUTED POLY(LACTIC ACID); POLYLACTIC ACID; POLYMER; TRIPTORELIN; UNCLASSIFIED DRUG;

ARTICLE; DEGRADATION; DRUG RELEASE; FLOW KINETICS; MOLECULAR WEIGHT; PARTICLE SIZE; SUSPENSION; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TEMPERATURE DEPENDENCE; VISCOSITY;

ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; INJECTIONS; LACTIC ACID; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERS; RHEOLOGY; SUSPENSIONS; TEMPERATURE; TIME FACTORS; TRIPTORELIN PAMOATE; VISCOSITY;

EID: 84863783596     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.04.015     Document Type: Article

References (25)

1. P. Vlieghe, V. Lisowski, J. Martinez, M. Khrestchatisky, Synthetic therapeutic peptides: science and market, Drug Discovery Today 15 (2010) 40-56.
2. M.J. Humphrey, P.S. Ringrose, Peptides and related drugs - a review of their absorption, metabolism, and excretion, Drug Metabolism Reviews 17 (1986) 283-310. (Pubitemid 17044695)
3. J.O. Johansson, L. Wiren, J. Oscarsson, B.A. Bengtsson, G. Johannsson, Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections, Growth Hormone & IGF Research 13 (2003) 306-315. (Pubitemid 37498182)
4. R. Oliyai, V.J. Stella, Prodrugs of peptides and proteins for improved formulation and delivery, Annual Review of Pharmacology and Toxicology 33 (1993) 521-544. (Pubitemid 23116017)
5. K.A. Witt, T.J. Gillespie, J.D. Huber, R.D. Egleton, T.P. Davis, Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability, Peptides 22 (2001) 2329-2343.
6. H. Berger, N. Heinrich, E. Albrecht, U. Kertscher, J. Oehlke, M. Bienert, H. Schafer, I. Baeger, B. Mehlis, Gonadotropin-releasing-hormone (Gnrh) analogs - relationship between their structure, proteolytic inactivation and pharmacokinetics in rats, Regulatory Peptides 33 (1991) 299-311.
7. F. Labrie, A. Belanger, V. Luu-The, C. Labrie, J. Simard, L. Cusan, J. Gomez, B. Candas, Gonadotropin-releasing hormone agonists in the treatment of prostate cancer, Endocrine Reviews 26 (2005) 361-379. (Pubitemid 40686649)
8. J.E. Fowler, J.E. Gottesman, C.F. Reid, G.L. Andriole, M.S. Soloway, Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer, Journal of Urology 164 (2000) 730-734. (Pubitemid 30637612)
9. B.J.A. Furr, F.G. Hutchinson, A biodegradable delivery system for peptides -preclinical experience with the gonadotropin-releasing-hormone agonist zoladex, Journal of Controlled Release 21 (1992) 117-127.
10. H. Okada, One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate, Advanced Drug Delivery Reviews 28 (1997) 43-70. (Pubitemid 27497673)
11. L.W. Wang, L. Kleiner, S. Venkatraman, Structure formation in injectable poly(lactide-co-glycolide) depots, Journal of Controlled Release 90 (2003) 345-354. (Pubitemid 36859965)
12. L. Arendt-Nielsen, H. Egekvist, P. Bjerring, Pain following controlled cutaneous insertion of needles with different diameters, Somatosensory and Motor Research 23 (2006) 37-43. (Pubitemid 44114991)
13. C. Wischke, S.P. Schwendeman, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, International Journal of Pharmaceutics 364 (2008) 298-327.
14. H. Kranz, G.A. Brazeau, J. Napaporn, R.L. Martin, W. Millard, R. Bodmeier, Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems, International Journal of Pharmaceutics 212 (2001) 11-18. (Pubitemid 32121946)
15. J.J. Rouse, F. Mohamed, C.F. van der Walle, Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA, International Journal of Pharmaceutics 339 (2007) 112-120. (Pubitemid 46977596)
16. T. Trimaille, R. Gurny, M. Moller, Synthesis and properties of novel poly(hexyl-substituted lactides) for pharmaceutical applications, Chimia 59 (2005) 348-352. (Pubitemid 40935282)
17. T. Trimaille, R. Gurny, M. Moller, Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems, Journal of Biomedical Materials Research Part A 80A (2007) 55-65. (Pubitemid 44913333)
18. L.R. Asmus, R. Gurny, M. Möller, Solutions as solutions - synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals, European Journal of Pharmaceutics and Biopharmaceutics 79 (2011) 584-591.
19. G. Novara, A. Galfano, S. Secco, V. Ficarra, W. Artibani, Impact of surgical and medical castration on serum testosterone level in prostate cancer patients, Urologia Internationalis 82 (2009) 249-255.
20. L.R. Asmus, R. Gurny, M. Moller, Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues, International Journal of Artificial Organs 34 (2011) 238-242.
21. T. Niwa, Y. Nakanishi, K. Danjo, One-step preparation of pharmaceutical nanocrystals using ultra cryo-milling technique in liquid nitrogen, European Journal of Pharmaceutical Sciences 41 (2010) 78-85.
22. C.H. Lee, V. Moturi, Y.Y. Lee, Thixotropic property in pharmaceutical formulations, Journal of Controlled Release 136 (2009) 88-98.
23. P.M. Conn, W.F. Crowley, Gonadotropin-releasing-hormone and its analogs, New England Journal of Medicine 324 (1991) 93-103.
24. V.J. Helm, B.W. Muller, Stability of gonadorelin and triptorelin in aqueous-solution, Pharmaceutical Research 7 (1990) 1253-1256.
25. J.M. Anderson, M.S. Shive, Biodegradation and biocompatibility of PLA and PLGA microspheres, Advanced Drug Delivery Reviews 28 (1997) 5-24. (Pubitemid 27497671)